For the Quarter Ending March 2026
Ìý
Omeprazole Prices in North America
- In the USA, the Omeprazole Price Index rose by 3.46% quarter-over-quarter, reflecting tighter imports and restocking.
- The average Omeprazole price for the quarter was approximately USD 57978.33/MT, reflecting CFR landed costs.
- Omeprazole Spot Price tightened as Omeprazole Production Cost Trend rose on higher intermediate feedstock costs.
- Omeprazole Price Forecast shows modest gains supported by restocking and limited export allotments from India.
- Omeprazole Demand Outlook remains steady with routine prescriptions and tender restocking supporting Price Index stability.
- Distributor inventories tightened to four weeks cover, prompting urgency and strengthening spot offers into Houston.
- Plants diverted capacity after GMP audits, reducing export quotas and widening offer spreads on Omeprazole.
- Freight and compliance costs supported CFR offers while USD stability moderated import-cost pressure on pricing.
Why did the price of Omeprazole change in March 2026 in North America?
- Tighter Indian and Chinese export allocations reduced availability, elevating landed costs and prompting forward buying.
- U.S. wholesalers accelerated safety-stock builds before April tenders, pulling forward demand and tightening spot supply.
- Freight rate increases and batch-release timelines from GMP re-inspections raised landed costs, pressuring March quotations.
Omeprazole Prices in APAC
- In China, the Omeprazole Price Index rose by 3.46% quarter-over-quarter, driven by tightened intermediate availability.
- The average Omeprazole price for the quarter was approximately USD 57833.33/MT based on Q1 benchmarks.
- Omeprazole Spot Price strengthened as Production Cost Trend remained muted, methanol feedstock stability supporting margins.
- Omeprazole Price Forecast points to moderate April gains owing to export restocking and disciplined exporters.
- Omeprazole Demand Outlook remains export-driven, lifting the Price Index while domestic procurement remains price-capped today.
- Exportable inventories tightened to roughly 2.3 weeks, reducing prompt availability and supporting seller bargaining positions.
- Large Yangtze River complexes operated above eighty percent, keeping output resilient despite smaller unit inspections.
- Export demand from Brazil, Germany, and the United States outpaced domestic buying, underpinning firmer FOB activity.
Why did the price of Omeprazole change in March 2026 in APAC?
- Environmental inspections across Jiangsu and Zhejiang reduced intermediate output, tightening supply and elevating export allocations.
- Offshore formulators accelerated restocking ahead of audits, increasing demand for certified high-purity Omeprazole FOB cargoes.
- Methanol-linked feedstock costs remained stable month-on-month, but compliance and logistics charges raised producer operating expenses.
Omeprazole Prices in Europe
- In France, the Omeprazole Price Index rose by 3.46% quarter-over-quarter, reflecting tighter export allotments abroad.
- The average Omeprazole price for the quarter was approximately USD 57933.33/MT, reflecting CFR import costs and elevated logistics premiums.
- Omeprazole Spot Price firmed in March due to constrained Asian availability and prolonged port congestion effects.
- Omeprazole Price Forecast indicates near-term firmness as importers restock and exporters maintain disciplined FOB offers.
- Omeprazole Production Cost Trend shows upward pressure from higher aromatic solvent and freight-linked energy surcharges.
- Omeprazole Demand Outlook remains stable, supported by reimbursement policies and steady hospital and retail prescription volumes.
- Omeprazole Price Index volatility increased as EU GMP audits trimmed export allocations and inventories declined below typical cover.
- Export demand and distributor inventories constrained supply while Indian and Chinese producers resumed disciplined shipments.
Why did the price of Omeprazole change in March 2026 in Europe?
- Supply tightened after EU GMP audits and origin quality upgrades limited Asian export allocations in March.
- Le Havre strikes increased container dwell time, raising demurrage costs and lifting landed CFR expenses.
- Higher freight rates and elevated feedstock-linked energy costs compounded cost pressures despite supportive reimbursement demand.
For the Quarter Ending December 2025
North America
• In the USA, the Omeprazole Price Index fell by 2.0% quarter-over-quarter, amid slightly firmer import costs.
• The average Omeprazole price for the quarter was approximately USD 61076.67/MT, reflecting import-led cost pass-through and distributor restocking.
• Tight December arrivals supported Omeprazole Spot Price momentum as selective allocations tightened the broader Omeprazole Price Index.
• Incremental compliance and higher intermediate costs maintained Omeprazole Production Cost Trend, pressuring margins for exporters.
• Inventory replenishment and formulary finalizations underpinned the Omeprazole Demand Outlook, sustaining steady wholesale procurement activity.
• Short-term Omeprazole Price Forecast points to measured increases driven by restocking and disciplined Asian export offers.
• Distributor inventories tightened to near two weeks coverage, amplifying import urgency and supporting the Omeprazole Price Index.
• Steady freight and no major plant shutdowns preserved supply reliability, limiting volatility despite firmer landed costs.
Why did the price of Omeprazole change in December 2025 in North America?
• Import-led cost pass-through from Asia tightened landed costs, nudging December quotations marginally higher for distributors.
• Year-end formulary finalizations and restocking elevated buying urgency, reducing visible spot availability near month end.
• Stable ocean freight and absent port congestion limited logistic disruption, leaving cost pressures as the primary price driver.
APAC
• In China, the Omeprazole Price Index fell by 1.98% quarter-over-quarter, driven by domestic procurement pressure.
• The average Omeprazole price for the quarter was approximately USD 55900.00/MT under FOB-Shanghai terms.
• Omeprazole Spot Price was supported by tightened crystallization capacity and expedited export loadings, reducing inventories.
• Omeprazole Price Forecast suggests upside into Q1-2026 as exporters and formulators replenish precautionary inventories.
• Omeprazole Production Cost Trend showed a slight elevation as the spot methylating agent has ticked higher recently.
• Omeprazole Demand Outlook remained constructive as Brazil and the United States buyers front-loaded ahead of year-end.
• Omeprazole Price Index stability reflected balanced coastal-production rates and steady feedstock-availability, keeping margins.
• Export demand and efficient Shanghai port operations supported timely shipments, limiting spot market volatility ahead.
Why did the price of Omeprazole change in December 2025 in APAC?
• Winter environmental audits temporarily reduced intermediate output, tightening supply and enabling price pass-through to exporters.
• Exporters rebuilt stocks ahead of year-end, increasing demand for FOB-Shanghai lots and drawing down inventories.
• Stable feedstock pricing limited production cost shock, while efficient port operations prevented logistics-driven premium escalation.
Europe
• In France, the Omeprazole Price Index fell by 2% quarter-over-quarter, reflecting slightly softer procurement activity.
• The average Omeprazole price for the quarter was approximately USD 55996.67/MT, reflecting Le Havre landed-costs.
• Omeprazole Spot Price remained stable; steady Asian export offers and normalized Le Havre port operations.
• Omeprazole Price Forecast indicates modest upward bias due to disciplined export offers and seasonal restocking.
• Omeprazole Production Cost Trend showed stability as key intermediates remained available and energy costs remained contained.
• Omeprazole Demand Outlook remains steady, supported by reimbursed PPI prescriptions, hospital tenders, and pharmacy restocking.
• Omeprazole Price Index reflected measured inventory rebuilds, balanced imports, and export demand to neighbouring markets.
• Major Indian and Chinese suppliers maintained shipments; logistic improvements at Le Havre eased supply friction.
Why did the price of Omeprazole change in December 2025 in Europe?
• Higher Asian export offers and restocking increased landed costs, marginally tightening available import volumes.
• Normalized port operations cut demurrage; insurance surcharges and rerouting maintained freight cost pressure.
• Sustained reimbursed PPI demand and tenders supported steady offtake, preventing sharp price declines.
For the Quarter Ending September 2025
North America
• In USA, the Omeprazole Price Index fell by 2.48% quarter-over-quarter, reflecting supply tightening from import frontloading.
• The average Omeprazole price for the quarter was approximately USD 62321.67/MT, reported by shipments and distributor settlements.
• Omeprazole Spot Price remained supported by accelerated imports and port delays, keeping near-term market tight.
• Omeprazole Price Forecast indicates modest upward trajectory due to inventory drawdowns and restocking by distributors.
• Omeprazole Production Cost Trend shows inflation-driven input costs and freight raising landed cost and margins.
• Omeprazole Demand Outlook remains stable but concentrated near-term as buyers frontload ahead of tariff risks.
• Omeprazole Price Index movements reflected port congestion and logistics cost pass-through affecting distributor pricing power.
• Inventory levels tightened modestly; export demand and purchases compressed spot volumes, supporting Price Index recovery.
Why did the price of Omeprazole change in September 2025 in North America?
• Import frontloading raised short-term demand, producing localized supply tightness despite generally adequate inventories at distributors.
• Rising freight costs and inflationary input pressures elevated landed costs, significantly pressuring seller pricing strategies.
• Typhoon-induced port delays and congestion extended lead times, reducing spot availability and increasing price volatility.
APAC
• In China, the Omeprazole Price Index fell by 2.46% quarter-over-quarter, export frontloading tightened logistics significantly.
• The average Omeprazole price for the quarter was approximately USD 62200/MT reflecting logistics passthrough pressure.
• Omeprazole Spot Price firmed as exporters prioritized early shipments, tightening immediate availability and supporting quotes.
• Omeprazole Price Forecast points to gains while the Price Index benefits from reduced inventory overhang.
• Omeprazole Production Cost Trend rose due to higher freight and weather-related disruptions, pressuring suppliers' margins.
• Omeprazole Demand Outlook remains positive short-term as international restocking ahead of holidays supports raw-material procurement.
• Omeprazole Price Index volatility reflected seasonal factory slowdowns and concentrated shipping congestion disrupting export rhythms.
• Suppliers used spot transactions to manage vessel constraints, aligning shipments with near-term orders, protecting margins.
Why did the price of Omeprazole change in September 2025 in APAC?
• Export frontloading increased demand temporarily, prompted by tariff suspension and accelerated shipments to Western buyers.
• Higher ocean freight and logistics disruptions raised supply costs and pressured producer pricing in September.
• Weather-related factory slowdowns reduced output intermittently, tightening short-term availability and prompting cautious restocking by buyers.
Europe
• In France, the Omeprazole Price Index fell by 2.435% quarter-over-quarter, driven by cautious pre-emptive restocking.
• The average Omeprazole price for the quarter was approximately USD 62303.33/MT, reflecting CFR Le Havre.
• Supply delays tightened availability and pushed Omeprazole Spot Price higher, while Omeprazole Price Index stayed stable.
• Omeprazole Price Forecast shows modest upticks driven by port congestion and buyer short-term restocking strategies.
• Rising freight and Asian raw material costs raised Omeprazole Production Cost Trend and squeezed supplier margins.
• Omeprazole Demand Outlook remains steady across hospitals and pharmacies, though cautious purchasing limits inventory rebuilds.
• Export disruptions and low inland water levels reduced throughput, tightening inventories and lifting short term prices.
• Major supplier scheduling changes and Chinese production slowdowns created intermittent supply tightness, supporting price firmness.
Why did the price of Omeprazole change in September 2025 in Europe?
• Port congestion and low inland water levels delayed imports, constraining French supply availability and delivery schedules.
• Chinese export price increases and production slowdowns raised replacement costs, transmitting higher landed costs to France.
• Precautionary restocking by importers amid logistical uncertainty tightened inventories, supporting upward pressure on domestic prices.
For the Quarter Ending June 2025
North America
• The Omeprazole Price Index in the USA dropped from USD 65,230/MT in April to USD 63,140/MT in May, before slightly rebounding in June.
• In April 2025, despite historically high tariffs (minimum 145%), suppliers absorbed costs and maintained a steady supply, causing the omeprazole spot price to fall due to weak buyer demand and elevated inventories.
• Strategic frontloading of shipments in early April, ahead of tariff implementation, led to inventory accumulation, contributing to a soft product demand outlook and delayed downstream ordering.
• By May 2025, the Price Index saw a sharp month-on-month drop of 3.20%, as a temporary U.S.–China tariff rollback failed to reverse cautious buyer sentiment.
• A major executive order in May imposing drug price benchmarks reduced new purchases, as pharmaceutical firms reassessed cost structures—adding pressure to the omeprazole price forecast.
• Imports from China in May declined 20.8% MoM, showing a deliberate inventory recalibration and reduced speculative buying, moderating the product production cost trend.
• In June 2025, early frontloaded imports during the U.S.–China trade truce, alongside inflation-linked cost increases, caused a minor Price Index rebound of 0.33%.
• Domestic demand remained steady in June, but buyers shifted to forward purchasing to shield against anticipated Q3 cost escalations, shaping the product demand outlook.
• Inflationary pressure in June prompted some upstream suppliers to adjust quotes upward, indicating a cautious shift in product price forecast behavior among distributors.
• For July 2025, prices are likely to remain stable or mildly increase, as distributors adopt shorter procurement cycles and lean inventory strategies, maintaining balance amid persistent supply-side caution.
China
• The Price Index for Omeprazole in China declined from USD 65,100/MT in April to USD 63,000/MT in May, followed by a slight rebound in June.
• April’s decline stemmed from weak omeprazole demand outlook, exacerbated by inventory overhang, reduced factory activity, and worsening port congestion across eastern China.
• U.S.-imposed 145% tariffs disrupted export orders, pushing down the product spot price as exporters issued steep discounts to clear backlogs.
• Domestic consumption remained sluggish in April due to economic uncertainty and logistical inefficiencies, leading to poor offtake and rising stockpiles.
• In May, the price index fell by 3.23% due to deepening oversupply and stagnant overseas buying interest despite hopes of mid-quarter demand recovery.
• A muted product production cost trend and under-utilized factory capacity led sellers to prioritize volume clearance at lower prices in May.
• In June, prices rose 0.32% as a 90-day U.S. tariff suspension prompted accelerated orders from North America, reviving short-term product demand outlook.
• Ocean freight GRIs also pushed logistics costs higher, allowing Chinese suppliers to raise product spot prices modestly.
• Manufacturers cautiously ramped up production in June, aiming to balance inventory reduction with renewed demand signals.
• For July 2025, omeprazole prices are likely to increase temporarily as international buyers replenish stocks post-Q2 lows, although inventory pressure will limit sharp gains.
Europe
• In April, the price index for Omeprazole in France declined sharply due to market oversupply caused by redirected US-bound shipments. This influx raised domestic inventory levels, while demand remained subdued, pushing the omeprazole spot price down to USD 65,175/MT.
• French importers conducted pre-buying ahead of the May Labour Day holiday, further saturating inventories. As a result, suppliers lowered prices to trigger buying activity amid stagnant market conditions and logistical inefficiencies at Le Havre and other EU ports.
• May 2025 saw a continued decline in the price index, dropping to USD 63,080/MT. Weak demand outlook from downstream buyers, such as pharmacies and hospitals, persisted, driven by sluggish retail sales and excess inventories.
• The mid-May removal of US tariffs led to a redirection of Chinese pharmaceutical exports toward Europe, aggravating France’s oversupply and triggering a deeper fall in the omeprazole spot price.
• Logistics delays across Northern European ports deterred new purchases, reinforcing a cautious stance among French buyers and delaying fresh procurements.
• In June, the price index marginally rebounded to USD 63,320/MT as port congestion worsened. This disrupted inbound Omeprazole shipments and created short-term tightness, especially with delays along key routes like the Rhine.
• Amid fears of prolonged disruptions, some wholesalers accelerated restocking in June, tightening near-term inventories and slightly lifting prices.
• Demand from France's hospital and pharmacy sectors remained stable, but importers adopted lean procurement strategies to balance inventory risks and delayed shipments.
• June’s omeprazole price forecast suggests upward momentum in July, as postponed orders from June are expected to be executed, leading to a temporary spike in demand and potential continuation of the price increase.
• Price index growth in July appears likely, with pharmacies and distributors who delayed restocking now expected to procure in bulk, placing upward pressure on prices despite a largely flat production cost trend.